These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 12962035)
1. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis]. Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035 [TBL] [Abstract][Full Text] [Related]
2. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651 [TBL] [Abstract][Full Text] [Related]
3. MR spectroscopy in multiple sclerosis. De Stefano N; Filippi M J Neuroimaging; 2007 Apr; 17 Suppl 1():31S-35S. PubMed ID: 17425732 [TBL] [Abstract][Full Text] [Related]
4. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153 [TBL] [Abstract][Full Text] [Related]
5. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520 [TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients. Siger-Zajdel M; Selmaj K Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349 [TBL] [Abstract][Full Text] [Related]
7. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients. Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888 [TBL] [Abstract][Full Text] [Related]
8. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Stromillo ML; Giorgio A; Rossi F; Battaglini M; Hakiki B; Malentacchi G; Santangelo M; Gasperini C; Bartolozzi ML; Portaccio E; Amato MP; De Stefano N Neurology; 2013 Jun; 80(23):2090-4. PubMed ID: 23635962 [TBL] [Abstract][Full Text] [Related]
9. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266 [TBL] [Abstract][Full Text] [Related]
10. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Narayana PA; Doyle TJ; Lai D; Wolinsky JS Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769 [TBL] [Abstract][Full Text] [Related]
11. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. Oh J; Pelletier D; Nelson SJ Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739 [TBL] [Abstract][Full Text] [Related]
12. 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders. Rovira A; Alonso J Neuroimaging Clin N Am; 2013 Aug; 23(3):459-74. PubMed ID: 23928200 [TBL] [Abstract][Full Text] [Related]
13. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
14. Proton MR spectroscopy in multiple sclerosis. Arnold DL; De Stefano N; Narayanan S; Matthews PM Neuroimaging Clin N Am; 2000 Nov; 10(4):789-98 ,ix-x. PubMed ID: 11359725 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658 [TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. Richards TL AJR Am J Roentgenol; 1991 Nov; 157(5):1073-8. PubMed ID: 1927795 [TBL] [Abstract][Full Text] [Related]
17. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. Assaf Y; Chapman J; Ben-Bashat D; Hendler T; Segev Y; Korczyn AD; Graif M; Cohen Y Magn Reson Imaging; 2005 Jul; 23(6):703-10. PubMed ID: 16198825 [TBL] [Abstract][Full Text] [Related]
18. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder. Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892 [TBL] [Abstract][Full Text] [Related]
19. Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis. Khan O; Shen Y; Bao F; Caon C; Tselis A; Latif Z; Zak I J Neuroimaging; 2008 Jul; 18(3):314-9. PubMed ID: 18304034 [TBL] [Abstract][Full Text] [Related]
20. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination? Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]